Sharon, MA, United States of America

Andrei A Zlota

This inventor holds 1 USPTO granted patent. Top assignee: Sepracor, Inc.. Active years: 2004.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Andrei A Zlota: Innovator in Pharmaceutical Chemistry

Introduction

Andrei A Zlota is a notable inventor based in Sharon, MA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the resolution of racemic compounds. His innovative approach has led to advancements in the production of enantiomerically enriched compositions.

Latest Patents

Zlota holds a patent for a method of resolving amlodipine racemate. This invention relates to methods of resolving racemic amlodipine into enantiomerically enriched compositions by precipitation with tartaric acid in the presence of a non-aqueous solvent, such as N,N′-dimethylacetamide. The molar ratio of tartaric acid to amlodipine is preferably less than 0.25:1.0 or greater than 0.75:1.0. This patent showcases his expertise in developing efficient methods for pharmaceutical applications.

Career Highlights

Andrei A Zlota is associated with Sepracor, Inc., where he has been instrumental in advancing research and development in pharmaceutical products. His work has contributed to the company's reputation for innovation in the industry. Zlota's dedication to his field is evident through his focused research and successful patent application.

Collaborations

Zlota has collaborated with notable colleagues, including Harold Scott Wilkinson and Chris Hugh Senanayake. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in pharmaceutical research.

Conclusion

Andrei A Zlota is a distinguished inventor whose work in resolving racemic amlodipine has made a significant impact in pharmaceutical chemistry. His contributions continue to influence the industry and pave the way for future innovations.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…